### 病生理 (_Crit Care_ 2013;17:206; _NEJM_ 2015;372:55)

•Deficit of water relative to sodium; by 定義, all hypernatremic 病人 are hypertonic

•Usually **loss of hypotonic fluid** (ie, “dehydration”); occasionally infusion of hypertonic fluid, post-ATN diuresis with loss of low or electrolyte-free water (_Am J Neph_ 2012;36:97)

•**_And_ impaired access to free water** (eg, intubation, Δ MS, elderly): hypernatremia is a powerful thirst stimulus, ∴ usually only develops in 病人 without access to H2O or ill

### Workup

•✔ Uosm, UNa, volume status (vital signs, orthostatics, JVP, skin turgor, BUN, Cr)

### Figure 4-5 Approach to hypernatremia
![](https://i.imgur.com/34hqp1o.png)
### Extrarenal H**2****O loss** (Uosm >700–800)

•**GI H2O loss:** vomiting, NGT drainage, osmotic diarrhea, fistula, lactulose, malabsorption

•**Insensible loss:** fever, exercise, ventilation, burns

### Renal H**2****O loss** (Uosm <700–800)

•**Diuresis:** osmotic (glucose, mannitol, urea), loop diuretics

•**Diabetes insipidus** (_J Clin Endocrinol Metab_ 2012;97:3426)

ADH deficiency (central) or resistance (nephrogenic)

**Central:** hypothalamic or posterior pituitary disease (congenital, trauma/surgery, infiltrative/IgG4); also idiopathic, hypoxic/ischemic encephalopathy (shock, Sheehan’s syndrome), anorexia, sarcoidosis, histiocytosis, drugs: EtOH, phenytoin, snake venom

tumors: craniopharyngioma, germinoma, lymphoma, leukemia, meningioma, pituitary

### Nephrogenic (_Annals_ 2006;144:186)

congenital (ADH receptor V2 mutation, aquaporin-2 mutation; _Ped Nephrol_ 2012;27:2183)

drugs: **lithium**, amphotericin, demeclocycline, foscarnet, cidofovir, ifosfamide

metabolic: **hypercalcemia**, **severe hypokalemia**, protein malnutrition, congenital

tubulointerstitial: **postobstruction**, **recovery phase of ATN**, PKD, sickle cell, Sjögren’s, amyloid, pregnancy (placental vasopressinase)

DI usually presents as severe polyuria and mild hypernatremia

### Other (Uosm >700–800)

•**Na overload:** hypertonic saline (eg, resuscitation with NaHCO3), mineralocorticoid excess

•**Seizures**, ↑ **exercise:** ↑ intracellular osmoles → H2O shifts → transient ↑ [Na]serum

### 治療 (_NEJM_ 2015;372:55)

•**Restore access to H****2****O** or supply daily requirement of H2O (≥1 L/d)

•**Replace free H****2****O deficit** (also replace concurrent volume deficit if appropriate):

![](https://i.imgur.com/MeaJTuf.png)

eg, 1 L D5W given to 70-kg man with [Na] = 160 mEq/L will ↓ [Na]serum by 3.7 mEq

nb, do not forget to correct Na if hyperglycemia also present

•Rate of correction depends on acuity of onset and risk:

chronic (>48 hr): ~12 mEq/d appears safe without risk of cerebral edema (_CJASN_ 2019;14:656)

acute (<48 hr): may ↓ Na by 2 mEq/L/h until Na 145

hyperacute (min-hrs) & life threatening (ICH, seizure): rapidly infuse D5W ± emergent HD

•_Estimate:_ in 70-kg man, 125 mL/h of free H2O will ↓ [Na] by ~0.5 mEq/L/h

•½ NS (77 mEq/L) or ¼ NS (38 mEq/L) provides both volume & free H2O (500 or 750 mL of free H2O per L, respectively); can give free H2O via NGT/OGT

•Formulas provide only estimates; ∴ recheck serum Na frequently

•**DI and osmotic diuresis:** see “Polyuria” section below

•**Na overload:** D5W + diuretic. Consider HD if life threatening (ICH, hypertonia, seizures).